论文信息 - Refining the hidradenitis suppurativa Hurley staging system for mild, moderate and severe disease

Refining the hidradenitis suppurativa Hurley staging system for mild, moderate and severe disease

ized scleroderma: a retrospective analysis of 344 patients with paediatricor adult-onset disease. Br J Dermatol 2015; 172:722–8. 4 Martini G, Fadanelli G, Agazzi A et al. Disease course and long-term outcome of juvenile localized scleroderma: experience from a single pediatric rheumatology centre and literature review. Autoimmun Rev 2018; 17:727–34. 5 Weibel L, Sampaio MC, Visentin MT et al. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 2006; 155:1013–20. 6 Li SC, Torok KS, Pope E et al. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) 2012; 64:1175–85.

J. Ingram

[1] A. Vossen,et al. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment , 2019, The British journal of dermatology.

[2] D. Presser,et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity , 2017, The British journal of dermatology.

[3] V. Piguet,et al. Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process , 2016, The British journal of dermatology.

[4] A. Finlay,et al. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[5] E. Prens,et al. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group. , 2017, Acta dermato-venereologica.

[6] T Fredriksson,et al. Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.